Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis

By sjmartinez • May 1, 2024

Gu Y, Gebremariam T, Alkhazraji S, Youssef E, El-Gamal S, Matkovits T, Cobb J, Mannino R, Ibrahim AS. Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis. Antimicrob Agents Chemother. 2024 Apr 30:e0154023. doi: 10.1128/aac.01540-23. Epub ahead of print. PMID: 38687015.

Tags: Amphotericin B, antifungal agents, Harbor UCLA, Infectious Diseases, lipid nanocrystal, liposomal amphotericin B, MAT2203, mucor, mucormycosis, murine, oral amphotericin B, Publications, Rhizopus

The Association of Fibrate Use with Kidney Outcomes and Mortality

Takahashi R, Shen J, Tran D, Elali I, Dai T, Shah A, Dukkipati R, Ismail A, Sumida K, Thomas F, Rhee CM, Kovesdy CP, Kalantar-Zadeh[...]

Plaque Begets Plaque, ApoB Does Not: Longitudinal Data From the KETO-CTA Trial

Soto-Mota A, Norwitz NG, Manubolu VS, Kinninger A, Wood TR, Earls J, Feldman D, Budoff M. Plaque Begets Plaque, ApoB Does Not: Longitudinal Data From[...]

Hypertrophic cardiomyopathy diagnosed by coronary computed tomography angiography: a case report

Condello M, Krishnan S, Budoff MJ. Hypertrophic cardiomyopathy diagnosed by coronary computed tomography angiography: a case report. Coron Artery Dis. 2025 Apr 7. doi: 10.1097/MCA.0000000000001435.[...]